Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

By sjmartinez • January 29, 2025

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA. Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093/cid/ciae648. Epub ahead of print. PMID: 39873495.

Tags: antiretroviral agents, Cabotegravir, Health policy, Infectious Diseases, lenacapavir, Pre-exposure prophylaxis, Publications

Correction: Empowering Women’s PrEP Choices: Qualitative Insights into Long-Acting PrEP Preferences and Decision-Making during Pregnancy and Breastfeeding in South Africa and Botswana

Chen-Charles J, De Vos L, Vundhla P, Gebengu A, Rousseau E, Bekker LG, Peters R, Mussa A, Morroni C, Toska E, Babalola CM, Klausner JD,[...]

Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

Costa Monteiro AC, Pickering H, Sarma A, Taylor CS, Jenkins MM, Hsu FM, Nadel B, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA,[...]

Ebola virus in Kasai revives 50-year-old questions on viral latency

Bryan ME, Nzanzu Vivalya BM, Geisbert TW, Judson SD, Munster V. Ebola virus in Kasai revives 50-year-old questions on viral latency. Lancet. 2025 Oct 10:S0140-6736(25)01973-7.[...]